Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Surgical/Operating Microscopes market in this environment.
In terms of revenue, this research report indicated that the global Surgical/Operating Microscopes market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Surgical/Operating Microscopes industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Leica Microsystems aims at producing XX K Units Surgical/Operating Microscopes in 2020, with XX % production to take place in global market, Carl Zeiss accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Surgical/Operating Microscopes Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Surgical/Operating Microscopes Market
Leica Microsystems
Carl Zeiss
Topcon
BMS Medical
Alcon Laboratories
Takagi
ACCU-Scope
Alltion (Wuzhou)
ARRI Medical
HAAG-Streit Surgical
Olympus IMS
Roslane Meditech
Moeller-Wedel
PEMED
...
Major Type of Surgical/Operating Microscopes Covered in Prudent Markets report:
On Casters Operating Microscopes
Wall Mounted Operating Microscopes
Table Top Operating Microscopes
Ceiling Mounted Operating Microscopes
Application Segments Covered in Prudent Markets Market
Hospitals
Outpatient Facilities
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Surgical/Operating Microscopes Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 On Casters Operating Microscopes -Product Introduction and Major Manufacturers
1.1.2 Wall Mounted Operating Microscopes -Product Introduction and Major Manufacturers
1.1.3 Table Top Operating Microscopes -Product Introduction and Major Manufacturers
1.1.4 Ceiling Mounted Operating Microscopes -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Surgical/Operating Microscopes Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Surgical/Operating Microscopes Market
3.1.1 Top Companies leading Surgical/Operating Microscopes Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Surgical/Operating Microscopes Market
3.2.1 Top Companies leading Surgical/Operating Microscopes Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Surgical/Operating Microscopes Market
3.3.1 Top Companies leading Surgical/Operating Microscopes Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Surgical/Operating Microscopes Market
3.4.1 Top Companies leading Surgical/Operating Microscopes Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Surgical/Operating Microscopes Market
3.5.1 Top Companies leading Surgical/Operating Microscopes Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Surgical/Operating Microscopes Market
3.6.1 Top Companies leading Surgical/Operating Microscopes Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Surgical/Operating Microscopes Market
3.7.1 Top Companies leading Surgical/Operating Microscopes Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Surgical/Operating Microscopes Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Surgical/Operating Microscopes Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Surgical/Operating Microscopes Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Surgical/Operating Microscopes Sales and Growth Rate (2021-2027)
5.2 Global Surgical/Operating Microscopes Sales Value and Growth Rate (2021-2027)
6 Surgical/Operating Microscopes Competitive Analysis
6.1 Leica Microsystems
6.1.1 Leica Microsystems Company Profiles
6.1.2 Leica Microsystems Product Introduction
6.1.3 Leica Microsystems Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Carl Zeiss
6.2.1 Carl Zeiss Company Profiles
6.2.2 Carl Zeiss Product Introduction
6.2.3 Carl Zeiss Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Topcon
6.3.1 Topcon Company Profiles
6.3.2 Topcon Product Introduction
6.3.3 Topcon Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 BMS Medical
6.4.1 BMS Medical Company Profiles
6.4.2 BMS Medical Product Introduction
6.4.3 BMS Medical Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Alcon Laboratories
6.5.1 Alcon Laboratories Company Profiles
6.5.2 Alcon Laboratories Product Introduction
6.5.3 Alcon Laboratories Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Takagi
6.6.1 Takagi Company Profiles
6.6.2 Takagi Product Introduction
6.6.3 Takagi Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 ACCU-Scope
6.7.1 ACCU-Scope Company Profiles
6.7.2 ACCU-Scope Product Introduction
6.7.3 ACCU-Scope Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Alltion (Wuzhou)
6.8.1 Alltion (Wuzhou) Company Profiles
6.8.2 Alltion (Wuzhou) Product Introduction
6.8.3 Alltion (Wuzhou) Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 ARRI Medical
6.9.1 ARRI Medical Company Profiles
6.9.2 ARRI Medical Product Introduction
6.9.3 ARRI Medical Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 HAAG-Streit Surgical
6.10.1 HAAG-Streit Surgical Company Profiles
6.10.2 HAAG-Streit Surgical Product Introduction
6.10.3 HAAG-Streit Surgical Surgical/Operating Microscopes Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Olympus IMS
6.12 Roslane Meditech
6.13 Moeller-Wedel
6.14 PEMED
7 Conclusion